1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 34; pp. S982 - S983
Main Authors Laccetti, A.L., Chatta, G., Kyriakopoulos, C., Iannotti, N., Hotte, S.J., Markowski, M.C., Pili, R., Vuky, J., Zhang, J., Saad, F., Villaluna, K., Younginger, B., Le Moigne, R., Cesano, A.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2023
Online AccessGet full text
ISSN0923-7534
1569-8041
DOI10.1016/j.annonc.2023.09.2761

Cover

Loading…
Author Younginger, B.
Kyriakopoulos, C.
Le Moigne, R.
Chatta, G.
Markowski, M.C.
Iannotti, N.
Cesano, A.
Saad, F.
Pili, R.
Laccetti, A.L.
Vuky, J.
Hotte, S.J.
Zhang, J.
Villaluna, K.
Author_xml – sequence: 1
  givenname: A.L.
  surname: Laccetti
  fullname: Laccetti, A.L.
  organization: Department of Medicine, Division of Solid Tumor Oncology, MSKCC - Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 2
  givenname: G.
  surname: Chatta
  fullname: Chatta, G.
  organization: Oncology Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
– sequence: 3
  givenname: C.
  surname: Kyriakopoulos
  fullname: Kyriakopoulos, C.
  organization: Hematology/Oncology, UW Carbone Cancer Center, Madison, WI, USA
– sequence: 4
  givenname: N.
  surname: Iannotti
  fullname: Iannotti, N.
  organization: Oncology Department, Hematology Oncology Associates of the Treasure Coast, Fort Pierce, FL, USA
– sequence: 5
  givenname: S.J.
  surname: Hotte
  fullname: Hotte, S.J.
  organization: Oncology Department, JCC - Juravinski Cancer Centre - Hamilton Health Sciences, Hamilton, Ontario, ON, Canada
– sequence: 6
  givenname: M.C.
  surname: Markowski
  fullname: Markowski, M.C.
  organization: Oncology Department, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA
– sequence: 7
  givenname: R.
  surname: Pili
  fullname: Pili, R.
  organization: Medicine Department, University of Buffalo - Clinical and Translational Research Center, Buffalo, NY, USA
– sequence: 8
  givenname: J.
  surname: Vuky
  fullname: Vuky, J.
  organization: Division of Hematology & Medical Oncology, OHSU Knight Cancer Institute - Center for Health and Healing Building 2, Portland, OR, USA
– sequence: 9
  givenname: J.
  surname: Zhang
  fullname: Zhang, J.
  organization: Genito Urinary, H. Lee Moffitt Cancer Center & Research Institute - Magnolia Campus, Tampa, FL, USA
– sequence: 10
  givenname: F.
  surname: Saad
  fullname: Saad, F.
  organization: Urology Department, Hospital St. Luc du CHUM, Montreal, QC, Canada
– sequence: 11
  givenname: K.
  surname: Villaluna
  fullname: Villaluna, K.
  organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA
– sequence: 12
  givenname: B.
  surname: Younginger
  fullname: Younginger, B.
  organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA
– sequence: 13
  givenname: R.
  surname: Le Moigne
  fullname: Le Moigne, R.
  organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA
– sequence: 14
  givenname: A.
  surname: Cesano
  fullname: Cesano, A.
  organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA
BookMark eNqFUU1v1DAQtVCR2BZ-AtIcdw9J_bF2YjggFBWIVIkIwdlynInqVTZZ2V4q-IH8LpwuJy49jT0z7-nNe9fkal5mJOQtoyWjTN0eSjvnlis55aKkuuSVYi_Ihkmli5ru2RXZUM1FUUmxf0WuYzxQSpXmekP-sJqJDroHGxHa27aFFLydYBlhCbnedW1RiVqBn8Etx97PNvllhkefHgDn33Y6J3v0A8I2_3brzskGHCAt6xjslLWu4CMmG1MGO3D5EZ5oioDR5-6c4BSWdYx5OjsMsD0237pmB_HcH9Cl-A6acwi4bl60wrZrd5AJzlOKr8nL0U4R3_yrN-THp7vvzZfi_uvntvl4XzhOGSu4HrUYBos1l1KMvaCO1lIOqud2T1E6VjtKUQmpOdv3TFth1agGSXvlhqoSN0ReeF2WGwOO5hT80YZfhlGzhmEO5hKGWcMwVJs1jIx7_x_O-fRkQXbCT8-iP1zQmE_76TGY6DxmmwYfsjdmWPwzDH8B-56rhQ
CitedBy_id crossref_primary_10_1080_14737140_2024_2379913
ContentType Journal Article
Copyright 2023 European Society for Medical Oncology
Copyright_xml – notice: 2023 European Society for Medical Oncology
DBID AAYXX
CITATION
DOI 10.1016/j.annonc.2023.09.2761
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1569-8041
EndPage S983
ExternalDocumentID 10_1016_j_annonc_2023_09_2761
S0923753423035986
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6J9
70D
AABJS
AABMN
AAEDW
AAESY
AAIAV
AAIYJ
AAJKP
AAJQQ
AAKAS
AAKUH
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEIU
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AIKOY
AITUG
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASMCH
ASPBG
ATTQO
AVWKF
AWCFO
AXUDD
AZFZN
AZQFJ
BAWUL
BAYMD
BEYMZ
BGNMA
BGYMP
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CASEJ
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
DPORF
DPPUQ
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KC5
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
AAGQS
AALRI
AAYWO
AAYXX
ABNGD
ACUKT
ACVFH
ADCNI
ADVLN
AEHUL
AEUPX
AFETI
AFJKZ
AFPUW
AFSHK
AGCQF
AGQPQ
AIGII
AKBMS
AKRWK
AKYEP
APXCP
CITATION
H13
ID FETCH-LOGICAL-c2011-29f93ddae82553fb30c0855d6b2a40e5c18c00e6359214b19a3a6f6d50b6cd773
ISSN 0923-7534
IngestDate Tue Jul 01 04:13:48 EDT 2025
Thu Apr 24 23:08:53 EDT 2025
Fri Feb 23 02:35:47 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2011-29f93ddae82553fb30c0855d6b2a40e5c18c00e6359214b19a3a6f6d50b6cd773
OpenAccessLink http://www.annalsofoncology.org/article/S0923753423035986/pdf
ParticipantIDs crossref_primary_10_1016_j_annonc_2023_09_2761
crossref_citationtrail_10_1016_j_annonc_2023_09_2761
elsevier_sciencedirect_doi_10_1016_j_annonc_2023_09_2761
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2023
2023-10-00
PublicationDateYYYYMMDD 2023-10-01
PublicationDate_xml – month: 10
  year: 2023
  text: October 2023
PublicationDecade 2020
PublicationTitle Annals of oncology
PublicationYear 2023
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0006929
Score 2.42728
SourceID crossref
elsevier
SourceType Enrichment Source
Index Database
Publisher
StartPage S982
Title 1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
URI https://dx.doi.org/10.1016/j.annonc.2023.09.2761
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXSBCh6Kbqi6YY59ODAkKJQm9WbYaSNmgVGFjQ3gaQoxKktGa18aD6w39NP6IxI2WprdMlFsCiSGmiexZnRzCNjb6IwEQHnsYPWqkYHxZOOHBSB48tQo9-TKJlTcfLxSXRwEXy4DC83Nr53spYWtXTVzdq6kttoFdtQr1Ql-x-aXU6KDfgb9YtH1DAe_0nHuG764_74CleiforTpGnf7MKBFmBTeb8_Th3ab7Nvss3RCzb6bqKvurwRKJ2YTfLG0MRzihEss9LRKsWmvphWhllkpmtB9UcT1Veipdt10F0nE7SsKdWrKU-iRDJFDBV8MBudjkc06ZeFpIBPk3_XUkLNjdzUb5xSJ5xqMTXMUu5v_M5VqX76AnAklNK1SUYYukduJ0-hNhbx-2Xb4Vd8Kp-qebWYmqzC0fJSKsqystOcuN0YCF9l09nAXFucs8qEaiKc2BG9MROv0Pb9HiUOUS51FwDbw7zBzxKzGZK1BvDUX7vSmKDHtUtSlsSFyX0izOWx4Zb_hcT7jIQhWdDjI87E6A7b4ujY8E22NTw8_Xi4tB6ihBt-SCv8qupsd-3N1ttTHRvp_AG7b50bGBqkPmQbunzE7h7b9I3H7FsDWGgAC-lumkIDV6gKILhCC1eYlNCBKxBcoQtX6OHZDrRQhbqiy9BAlQavoArroAotVMFAFXoNUHeghelbsCCFuZEVeuN0ByxAn7CLd_vnowPHbiTiqOYTAE-KxM9zoQfoQPuF9D1F6Zl5JLkIPB2qvYHyPI22d8L3ArmXCF9ERZSHnoxUHsf-U7aJD14_YyAkKkbHSkU6DOJIirgIioHmSRjnoYyLbRa06siUZdmnzV6mWZtOeZ0ZLWakxcxLMtLiNnOXw-aGZuZvAwatrjNrKxsbOEOA_nno89sPfcHurf5-L9lm_XmhX6FRXsvXFsc_ADWZ4PY
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1813P+Phase+I%2FII+trial+of+oral+EPI-7386+in+combination+with+enzalutamide+%28enz%29+compared+to+enz+alone+in+metastatic+castration-resistant+prostate+cancer+%28mCRPC%29+subjects%3A+Current+phase+I+%28PI%29+results&rft.jtitle=Annals+of+oncology&rft.au=Laccetti%2C+A.L.&rft.au=Chatta%2C+G.&rft.au=Kyriakopoulos%2C+C.&rft.au=Iannotti%2C+N.&rft.date=2023-10-01&rft.pub=Elsevier+Ltd&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=34&rft.spage=S982&rft.epage=S983&rft_id=info:doi/10.1016%2Fj.annonc.2023.09.2761&rft.externalDocID=S0923753423035986
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon